Literature DB >> 30414672

Identification of a rare homozygous c.790C>T variation in the TFB2M gene in Korean patients with autism spectrum disorder.

Chan Bae Park1, Vit-Na Choi2, Jae-Bum Jun3, Ji-Hae Kim4, Youngsoo Lee5, Jinhyuk Lee6, GyuTae Lim6, Jeonghyun Kim2, Seon-Yong Jeong7, Shin-Young Yim8.   

Abstract

Mitochondrial dysfunction and subsequent enhanced oxidative stress is implicated in the pathogenesis of autism spectrum disorder (ASD). Mitochondrial transcription factor B2 (TFB2M) is an essential protein in mitochondrial gene expression. No reports have described TFB2M mutations and variations involved in any human diseases. We identified a rare homozygous c.790C>T (His264Tyr) variation in TFB2M gene in two Korean siblings with ASD by whole-exome sequencing. The roles of the TFB2M variation in the pathogenesis of ASD were investigated. Patient fibroblasts revealed increased transcription of mitochondrial genes and mitochondrial function in terms of ATP, membrane potential, oxygen consumption, and reactive oxygen species (ROS). Overexpression of the TFB2M variant in primary-cultured fibroblasts demonstrated significantly increased transcription of mitochondrial genes and mitochondrial function compared with overexpression of wild-type TFB2M. Molecular dynamics simulation of the TFB2M variant protein suggested an increase in the rigidity of the hinge region, which may cause alterations in loading and/or unloading of TFB2M on target DNA. Our results suggest that augmentation of mitochondrial gene expression and subsequent enhancement of mitochondrial function may be associated with the pathogenesis of ASD in Korean patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorder; Mitochondria; Reactive oxygen species; TFB2M; Transcription factors

Mesh:

Substances:

Year:  2018        PMID: 30414672     DOI: 10.1016/j.bbrc.2018.10.194

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Organization and expression of the mammalian mitochondrial genome.

Authors:  Oliver Rackham; Aleksandra Filipovska
Journal:  Nat Rev Genet       Date:  2022-04-22       Impact factor: 59.581

2.  POLRMT mutations impair mitochondrial transcription causing neurological disease.

Authors:  Monika Oláhová; Bradley Peter; Zsolt Szilagyi; Hector Diaz-Maldonado; Meenakshi Singh; Ewen W Sommerville; Emma L Blakely; Jack J Collier; Emily Hoberg; Viktor Stránecký; Hana Hartmannová; Anthony J Bleyer; Kim L McBride; Sasigarn A Bowden; Zuzana Korandová; Alena Pecinová; Hans-Hilger Ropers; Kimia Kahrizi; Hossein Najmabadi; Mark A Tarnopolsky; Lauren I Brady; K Nicole Weaver; Carlos E Prada; Katrin Õunap; Monica H Wojcik; Sander Pajusalu; Safoora B Syeda; Lynn Pais; Elicia A Estrella; Christine C Bruels; Louis M Kunkel; Peter B Kang; Penelope E Bonnen; Tomáš Mráček; Stanislav Kmoch; Gráinne S Gorman; Maria Falkenberg; Claes M Gustafsson; Robert W Taylor
Journal:  Nat Commun       Date:  2021-02-18       Impact factor: 14.919

3.  Autism spectrum disorder: A mitochondrial disorder.

Authors:  Josef Finsterer
Journal:  Iran J Child Neurol       Date:  2021

Review 4.  The Mitochondrial Dysfunction Hypothesis in Autism Spectrum Disorders: Current Status and Future Perspectives.

Authors:  Luigi Citrigno; Maria Muglia; Antonio Qualtieri; Patrizia Spadafora; Francesca Cavalcanti; Giovanni Pioggia; Antonio Cerasa
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

5.  Positive Selection in Gene Regulatory Factors Suggests Adaptive Pleiotropic Changes During Human Evolution.

Authors:  Vladimir M Jovanovic; Melanie Sarfert; Carlos S Reyna-Blanco; Henrike Indrischek; Dulce I Valdivia; Ekaterina Shelest; Katja Nowick
Journal:  Front Genet       Date:  2021-05-17       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.